Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
03/1998
03/19/1998CA2265927A1 Monoclonal antibodies against the extracellular domain of human vegf-receptor protein (kdr)
03/19/1998CA2264748A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions
03/19/1998CA2264541A1 Human protein kinases
03/19/1998CA2262818A1 Modified amino acids, pharmaceuticals containing these compounds and methods for their production
03/18/1998EP0828754A1 Dipeptides which promote release of growth hormone
03/18/1998EP0828742A1 Diazepino-indoles as phosphodiesterase iv inhibitors
03/18/1998EP0828518A1 Gene transfer for treating a connective tissue of a mammalian host
03/18/1998EP0828496A1 Use of alendronate for the prevention of osteoporosis
03/17/1998US5728844 Immunotherapeutic agents
03/17/1998US5728724 Treatment of postmenopause syndrome, osteoporosis, cardiovascular disorders and estrogen dependent cancer
03/17/1998US5728677 Administering a specified polypeptide to a mammal
03/12/1998WO1998009985A2 Anti-inflammatory peptides and uses thereof
03/12/1998WO1998009977A1 Tetrahydronapthalene derivatives and their therapeutic use
03/12/1998WO1998009969A1 Novel aryl-pyridazines
03/12/1998WO1998009961A1 Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
03/12/1998WO1998009957A1 Compounds for and a method of inhibiting matrix metalloproteinases
03/12/1998WO1998009940A1 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
03/12/1998WO1998009934A1 Matrix metalloproteinase inhibitors and their therapeutic uses
03/12/1998WO1998009631A1 Transdermal therapeutical approach involving a combination of active substances containing oestriol
03/12/1998WO1998009630A1 Compounds and methods
03/12/1998WO1998009626A1 Methods for in vivo reduction of iron levels and compositions useful therefor
03/12/1998WO1998009619A1 Novel methods
03/12/1998WO1998009519A1 Method of treating post menopausal diseases, including osteoporosis
03/12/1998DE19638745A1 Monoklonale Antikörper gegen die extrazelluläre Domäne des menschlichen VEGF - Rezeptorproteins (KDR) Monoclonal antibodies against the extracellular domain of the human VEGF - receptor protein (KDR)
03/12/1998DE19636689A1 Neue Benzamidinderivate New benzamidine derivatives
03/12/1998CA2264943A1 Novel methods
03/12/1998CA2264942A1 Compounds and methods
03/12/1998CA2264798A1 Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
03/12/1998CA2264775A1 Method of treating post menopausal diseases, including osteoporosis
03/12/1998CA2264737A1 Tetrahydronaphthalene derivatives and their therapeutic use
03/12/1998CA2264285A1 Anti-inflammatory peptides and uses thereof
03/12/1998CA2263686A1 Methods for in vivo reduction of iron levels and compositions useful therefor
03/12/1998CA2263586A1 Novel aryl-pyridazines
03/12/1998CA2261655A1 Transdermal therapeutical approach involving a combination of active substances containing oestriol
03/12/1998CA2256716A1 Matrix metalloproteinase inhibitors and their therapeutic uses
03/12/1998CA2256631A1 Compounds for and a method of inhibiting matrix metalloproteinases
03/11/1998CN1175956A Novel protein and method for production of same
03/11/1998CN1175428A Medical ointment for hyperosteogeny
03/10/1998US5726186 For treating post-menopausal syndrome, uterine fibroid disease, endometriosis and aortal smooth muscle cell proliferation
03/10/1998US5726185 Binding of adhesive proteins to blood platelet aggregation and cell to cell adhesion
03/10/1998US5726168 Lipophilic benzothiophenes
03/10/1998US5726149 Treatment of glomerulonephritis with decorin
03/10/1998US5726148 Method of treating metabolic bone diseases with an IL-1 receptor
03/05/1998WO1998008853A1 Phosphinic acid amides as matrix metalloprotease inhibitors
03/05/1998WO1998008850A1 Spirocyclic metalloprotease inhibitors
03/05/1998WO1998008847A1 Substituted 6,5-hetero-bicyclic derivatives
03/05/1998WO1998008840A1 Integrin antagonists
03/05/1998WO1998008828A1 2-phenylmorpholin-5-one derivatives and pharmaceutical composition comprising the same
03/05/1998WO1998008827A1 Heterocyclic metalloprotease inhibitors
03/05/1998WO1998008825A1 1,4-heterocyclic metalloprotease inhibitors
03/05/1998WO1998008823A1 Heterocyclic metalloprotease inhibitors
03/05/1998WO1998008815A1 Substituted cyclic amine metalloprotease inhibitors
03/05/1998WO1998008814A1 Bidentate metalloprotease inhibitors
03/05/1998WO1998008802A1 Inhibitors of cysteine protease
03/05/1998WO1998008797A1 Naphthyl compounds, intermediates, compositions, and methods of use
03/05/1998WO1998008546A2 Therapeutic combinations of rar antagonists and rxr agonists and use thereof
03/05/1998WO1998008518A1 Compositions and methods for administering integrin receptor antagonists
03/05/1998WO1998008517A2 Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol
03/05/1998WO1998008513A1 Amorphous benzothiophenes, methods of preparation, and methods of use
03/05/1998WO1998008503A1 Therapeutic methods and compositions involving isoflavones
03/05/1998WO1998008494A1 Methods and compositions for the treatment of bone resorption disorders, including osteoporosis
03/05/1998WO1998008480A2 Method of using tetracycline compounds for inhibition of nitric oxide production
03/05/1998WO1998001554A3 Secreted proteins and polynucleotides encoding them
03/05/1998WO1998001552A3 Secreted proteins and polynucleotides encoding them
03/05/1998DE19635883A1 Transdermales therapeutisches System mit einer Östriol enthaltenden Wirkstoffkombination Transdermal therapeutic system with a combination of active ingredients containing estriol
03/05/1998CA2670296A1 Method of using tetracycline compounds for inhibition of nitric oxide production
03/05/1998CA2265049A1 Therapeutic methods and compositions involving isoflavones
03/05/1998CA2264715A1 Methods and compositions for the treatment of bone resorption disorders, including osteoporosis
03/05/1998CA2264131A1 Pharmaceutical composition containing osteogenesis-promoting substance
03/05/1998CA2264045A1 Heterocyclic metalloprotease inhibitors
03/05/1998CA2264044A1 Spirocyclic metalloprotease inhibitors
03/05/1998CA2263999A1 Integrin antagonists
03/05/1998CA2263998A1 Compositions and methods for administering integrin receptor antagonists
03/05/1998CA2263932A1 1,4-heterocyclic metalloprotease inhibitors
03/05/1998CA2263928A1 Substituted cyclic amine metalloprotease inhibitors
03/05/1998CA2263917A1 Heterocyclic metalloprotease inhibitors
03/05/1998CA2263914A1 Bidentate metalloprotease inhibitors
03/05/1998CA2263817A1 Therapeutic combinations of rar antagonists and rxr agonists and use thereof
03/05/1998CA2263175A1 Amorphous benzothiophenes, methods of preparation, and methods of use
03/04/1998EP0826774A2 Staphylococcal Fab I enoyl-ACP reductase
03/04/1998EP0826685A1 Stable, long acting salts of carboxamides for the treatment of joint disease
03/04/1998EP0826683A1 Benzo[B]thiophene compounds, intermediates, processes, compositions, and methods
03/04/1998EP0826682A1 Amorphous benzothiophenes, methods of preparation, and methods of use
03/04/1998EP0826679A2 Naphthyl compounds, intermediates, compositions, and method of use
03/04/1998EP0826670A1 Naphthalene compounds, intermediates, formulations, and methods
03/04/1998EP0825989A1 Substituted oxazoles for the treatment of inflammation
03/04/1998EP0825872A1 Pharmaceutical administration form of parathyroid hormone having an active ingredient release period of from two to six hours
03/04/1998CN1174836A Novel imino derivatives as inhibitors of bone resorption and vitronectin receptor antagonists
03/04/1998CN1174741A Traditional Chinese medicinal pill for curing osteonecrosis
03/04/1998CN1174713A Powder medicine composition for quick growth of fracture setting
03/03/1998US5723577 Analogs of parathyroid hormone
03/03/1998US5723480 Adhesion receptor antagonists III
03/03/1998US5723474 Benzothiophene compounds, intermediates, compositions, and methods
03/03/1998US5723444 Enzyme inhibitors and anticoagulants
03/03/1998US5723315 Secreted proteins and polynucleotides encoding them
02/1998
02/28/1998CA2213814A1 Naphthalene compounds, intermediates, formulations, and methods
02/26/1998WO1998007859A2 Secreted proteins and polynucleotides encoding them
02/26/1998WO1998007853A1 Secreted proteins and polynucleotides encoding them
02/26/1998WO1998007697A1 Arylsulfonylamino hydroxamic acid derivatives
02/26/1998WO1998007448A1 Anti-carious chewing gums, candies, gels, toothpastes and dentifrices
1 ... 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 ... 820